During the past decade, North Shore Diabetes and Endocrine Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Shore Diabetes and Endocrine Associates" #1 sponsor was "Mannkind Corporation" with 7 trials, followed by "Joslin Diabetes Center" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "DeveloGen Israel, Ltd." with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Shore Diabetes and Endocrine Associates" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator, "Mylan GmbH" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "North Shore Diabetes and Endocrine Associates" are "Type 2 Diabetes" (5 trials), "Diabetes Mellitus, Type 1" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Type 1 Diabetes" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "North Shore Diabetes and Endocrine Associates" in a lesser frequency.

Most popular intervention types in "North Shore Diabetes and Endocrine Associates" are "Drug" (15 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Technosphere Insulin Inhalation Powder" (3 trials), "Salsalate" (2 trials), "Technosphere Insulin" (2 trials) and "Technosphere® Insulin Inhalation Powder" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Shore Diabetes and Endocrine Associates" are 16 trials for "All" genders.

Currently, there are NaN active trials in "North Shore Diabetes and Endocrine Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in North Shore Diabetes and Endocrine Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in North Shore Diabetes and Endocrine Associates, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".